James E. Bradner
EVP, Research and Development at Amgen Inc (AMGN) since December 2023
James E. Bradner has filed 7 insider reports with the SEC since December 2023, as EVP and research and Development at Amgen Inc (AMGN). The latest filing, on May 11, 2026, reports shares withheld for taxes or exercise price at Amgen Inc (AMGN).
- Filings
- 7
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where James E. Bradner is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP, Research and Developmentsince December 2023 | 30,016 | $457.93 | May 11, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 7, 2026AMGNEVP, Research and Development Bradner James E. covered exercise/tax liability with 446 shares, decreasing direct ownership by 1% to 30,016 unitsForm 4Shares withheld for taxes or exercise price
- May 6, 2026AMGNEVP, Research and Development Bradner James E. was granted 3,337 shares and covered exercise/tax liability with 407 shares, increasing direct ownership by 11% to 30,462 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 9, 2026AMGNEVP, Research and Development Bradner James E. covered exercise/tax liability with 3,104 shares, decreasing direct ownership by 10% to 27,378 unitsForm 4Shares withheld for taxes or exercise price
- May 6, 2025AMGNEVP, R&D, & Chief Sci. Officer Bradner James E. was granted 3,549 shares, increasing direct ownership by 14% to 29,753 unitsForm 4Grant or award
- May 7, 2024AMGNBradner James E. was granted 2,863 shares, increasing direct ownership by 13% to 25,438 unitsForm 4Grant or award
- Feb 9, 2024AMGNBradner James E. was granted 22,393 sharesForm 4Grant or award
- Dec 18, 2023AMGNJames E. Bradner became an insiderForm 3New insider
Compare James E. Bradner with
- James E. Bradner vs Omar Ishrak1 shared
- James E. Bradner vs Charles M Holley1 shared
- James E. Bradner vs David W Gibbs1 shared
- James E. Bradner vs Michael V Drake1 shared
- James E. Bradner vs Rachna Khosla1 shared
- James E. Bradner vs Matthew C. Busch1 shared
Other insiders at the same companies
- Omar IshrakAMGN
- Charles M HolleyAMGN
- David W GibbsAMGN
- Michael V DrakeAMGN
- Thomas J.W. DittrichAMGN
- Rachna KhoslaAMGN
- Matthew C. BuschAMGN
- Derek MillerAMGN
- Nancy A. GrygielAMGN
- Amy E MilesAMGN
- Ellen Jamison KullmanAMGN
- Mary E. KlotmanAMGN
- Tyler JacksAMGN
- Greg C. GarlandAMGN
- Robert EckertAMGN
- Brian DrukerAMGN
Questions about James E. Bradner
- What is James E. Bradner's role at Amgen Inc?
- James E. Bradner reports to the SEC as EVP and research and Development at Amgen Inc (AMGN), according to the latest filing on May 11, 2026.
- How many shares does James E. Bradner own?
- After the latest filing that states it, James E. Bradner directly owned 30,016 shares of Amgen Inc (AMGN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has James E. Bradner bought or sold stock recently?
- No open-market purchases or sales by James E. Bradner are on file. The filings report shares withheld for taxes or exercise price and grant or award.
- How do I get alerts when James E. Bradner files?
- Follow James E. Bradner on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by James E. Bradner (SEC CIK 0002005159). Totals count each trade once, skipping amendments whose original is on file, from Dec 20, 2023 on. View on SEC EDGAR